| Bioactivity | KRAS G12C inhibitor 59 is a KRAS G12C inhibitor with anticancer effects (WO2023036282A1, compound II)[1]. |
| Name | KRAS G12C inhibitor 59 |
| CAS | 2914919-88-1 |
| Formula | C32H39F6N7O5 |
| Molar Mass | 715.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yangyang Yu, et al. Crystal form of pyrimidine heterocyclic compound and preparation method therefor. WO2023036282A1. |
KRAS G12C inhibitor 59
CAS: 2914919-88-1 F: C32H39F6N7O5 W: 715.69
KRAS G12C inhibitor 59 is a KRAS G12C inhibitor with anticancer effects (WO2023036282A1, compound II).
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.